help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 11, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2656
A more recent version of this article appeared on June 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
93/6/2089    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Lawson, M. A.
Right arrow Articles by Chang, R. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lawson, M. A.
Right arrow Articles by Chang, R. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Diabetes and Insulin
Right arrow Female Endocrinology

Submitted on December 3, 2007
Accepted on February 29, 2008

Evidence for Insulin Suppression of Baseline Luteinizing Hormone in Women with Polycystic Ovarian Syndrome and Normal Women

Mark A. Lawson*, Sonia Jain, Shelly Sun, Ketan Patel, Pamela J. Malcolm, and R. Jeffrey Chang

Department of Reproductive Medicine, and Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA 92093

* To whom correspondence should be addressed. E-mail: mlawson{at}ucsd.edu.

Context: In PCOS women the relationship of insulin to LH secretion and responses to GnRH remains unresolved. A rigorous analytical examination of this relationship has not been performed.

Objective: To determine the relationship of basal LH secretion and responses to GnRH, insulin and other endocrine variables in normal and PCOS women.

Design: In PCOS and normal women, mean composite 12 h LH secretion was analyzed for correlating factors. LH responses to varying doses of GnRH during a fixed rate of insulin infusion and LH responses to a fixed dose of GnRH during varying doses of insulin infusion were analyzed for contributing factors.

Setting: General Clinical Research Center, University of California, San Diego

Patients: 18 PCOS and 21 normal women underwent studies of frequent blood sampling and GnRH stimulation before and during insulin infusion.

Main outcome measures: Group mean composite 12h LH levels were assessed with respect to other endocrine variables. In addition, LH responses to GnRH with or without insulin infusion were assessed.

Results: In normal women, insulin negatively predicted mean LH. In PCOS, the combined effect of BMI (negative) and testosterone (positive) predicted LH. The best predictor of LH was BMI and insulin combined. Basal LH and LH responses to GnRH were unaltered by insulin infusion in normal women. These measures were reduced during insulin infusion in PCOS women.

Conclusions: In PCOS, insulin infusion suppresses pituitary response to GnRH. In normal women, insulin negatively correlates with mean LH and suppresses GnRH response at a high infusion rate.


Key words: Luteinizing Hormone • Pituitary • Gonadotropins • Gonadotropin-Releasing Hormone







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society